CD8A and neoplasm: Our study demonstrated that VVL-GL7 led to a substantial augmentation in the number of memory T-cells within tumor tissues, particularly on day 14, and the proportion of CD4+ and CD8+ TCM and TEM cells was significantly higher than that of controls.